RSI low/high Values: [ 25 - 75 ]
* uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GILD
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Gilead stock after losing 0.741%
(Updated on May 24, 2024)

Sell candidate since May 23, 2024 Loss -0.74% PDF

The Gilead stock price fell by -0.741% on the last day (Friday, 24th May 2024) from $66.17 to $65.68. During the last trading day the stock fluctuated 1.87% from a day low at $65.21 to a day high of $66.43. The price has been going up and down for this period, and there has been a -0.42% loss for the last 2 weeks. Volume has increased on the last day by 359 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 6 million shares were bought and sold for approximately $391.13 million.

The stock lies in the middle of a falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -12.80% during the next 3 months and, with a 90% probability hold a price between $54.80 and $59.19 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GILD Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, May 09, 2024, and so far it has risen 1.70%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Gilead stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $67.20 and $66.76. A break-up above any of these levels will issue buy signals. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Gilead stock

Gilead finds support from accumulated volume at $65.42 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $1.22 between high and low, or 1.87%. For the last week the stock has had daily average volatility of 1.65%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GILD) For The Upcoming Trading Day Of Tuesday 28th

For the upcoming trading day on Tuesday, 28th we expect Gilead Sciences to open at $65.77, and during the day (based on 14 day Average True Range), to move between $64.55 and $66.81, which gives a possible trading interval of +/-$1.13 (+/-1.72%) up or down from last closing price. If Gilead Sciences takes out the full calculated possible swing range there will be an estimated 3.43% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $65.42 (0.40%) than the resistance at $66.76 (1.64%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Gilead Sciences stock A Buy?

Gilead holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.176 Sell Candidate Unchanged

Predicted Opening Price for Gilead Sciences of Tuesday, May 28, 2024

Fair opening price May 28, 2024 Current price
$65.77 ( 0.142%) $65.68

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GILD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 66.99 2.00 %
R2 66.53 1.29 %
R1 66.24 0.85 %
Current price: 65.68
Support S1 65.31 -0.567 %
S2 65.02 -1.01 %
S3 64.55 -1.72 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 73.69 12.20 %
R2 73.66 12.15 %
R1 66.76 1.64 %
Current price 65.68
Support S1 65.42 -0.396%
S2 65.27 -0.624%
S3 64.78 -1.37%

GILD Dividend Payout History

# Declaration Date Ex-Date Pay Date Amount Yield
1 Apr 25, 2024 Jun 14, 2024 Jun 27, 2024 $0.770 1.17%
2 Feb 06, 2024 Mar 14, 2024 Mar 28, 2024 $0.770 1.05%
3 Nov 01, 2023 Dec 14, 2023 Dec 28, 2023 $0.750 0.92%
4 Aug 03, 2023 Sep 14, 2023 Sep 28, 2023 $0.750 0.99%
5 Apr 25, 2023 Jun 14, 2023 Jun 29, 2023 $0.750 0.99%


What is the symbol for Gilead Stock and on which exchange is it traded?
The symbol for Gilead is GILD and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Gilead Stock?
Gilead holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Gilead Stock?
Gilead Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Gilead Stock.

What's the current price of Gilead Stock?
As of the end of day on the May 24, 2024, the price of an Gilead (GILD) share was $65.68.

What is the 52-week high and low for Gilead Stock?
The 52-week high for Gilead Stock is $87.86 and the 52-week low is $64.33.

What is the market capitalization of Gilead Stock?
As of the May 24, 2024, the market capitalization of Gilead is 81.827B.

When is the next earnings date for Gilead?
The upcoming earnings date for Gilead is Aug 01, 2024.
Click to get the best stock tips daily for free!

About Gilead Sciences

Gilead Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, V... GILD Profile

Top Fintech Company featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE